Usability and Robustness of the Wixela Inhub Dry Powder Inhaler

Background: Wixela Inhub is a generic version of Advair Diskus recently approved by the U.S. Food and Drug Administration. The Inhub inhaler delivers fluticasone propionate (FP)/salmeterol in a dry powder formulation. The goals of our studies were to demonstrate that the Inhub inhaler can be used by...

Descripción completa

Detalles Bibliográficos
Autores principales: Allan, Richard, Canham, Kelly, Wallace, Roisin, Singh, Dave, Ward, Jon, Cooper, Andrew, Newcomb, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060712/
https://www.ncbi.nlm.nih.gov/pubmed/32865454
http://dx.doi.org/10.1089/jamp.2020.1603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060712/
https://www.ncbi.nlm.nih.gov/pubmed/32865454
http://dx.doi.org/10.1089/jamp.2020.1603

Ejemplares similares